Back to company

VarCT Diagnostics ApS: Financial statements 2025

CVR: 38733567

VarCT Diagnostics ApS (CVR 38733567) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 176,862 and a net result of DKK -1,961,493 compared with DKK 779,245 the year before. That is a decrease of 94.8% compared with the year before. Equity amounted to DKK 2,238,264. The solvency ratio was 22%. The company had 5 employees in the financial year.

Gross Profit
176,862 kr.
Profit/Loss
-1,961,493 kr.
Equity
2,238,264 kr.
Total Assets
10,152,049 kr.
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-177 t.-2 mio.2.2 mio.5
2024-3.4 mio.779 t.4.2 mio.5
2023-442 t.-1.6 mio.3.4 mio.5
2022-89 t.-1.9 mio.5.1 mio.4
2021--483 t.-1.7 mio.7 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like VarCT Diagnostics ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

VarCT Diagnostics ApS: The 2024 annual report is outMay 27, 2025

VarCT Diagnostics ApS has published its annual report for 2024. Gross profit came to DKK 3,425,482, and the net result was DKK 779,245.

About VarCT Diagnostics ApS

VarCT Diagnostics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The company is owned by VAR2 PHARMACEUTICALS ApS and Sitour Management m.b.H.. The company has 4 employees. In 2025, the company reported a gross profit of DKK 176,862 and a net result of DKK -1,961,493 compared with DKK 779,245 the year before. Equity amounted to DKK 2,238,264.

Other financial years